Abstract
In recent years, there has been a growing interest, supported by a large number of experimental and epidemiological studies, for the beneficial effects of some phenolic substances, contained in commonly used spices and herbs, in preventing various age-related pathologic conditions, ranging from cancer to neurodegenerative diseases. Although the exact mechanisms by which polyphenols promote these effects remain to be elucidated, several reports have shown their ability to stimulate a general xenobiotic response in the target cells, activating multiple defense genes. Data from our and other laboratories have previously demonstrated that curcumin, the yellow pigment of curry, strongly induces heme-oxygenase-1 (HO-1) expression and activity in different brain cells via the activation of heterodimers of NF-E2-related factors 2 (Nrf2)/antioxidant responsive element (ARE) pathway. Many studies clearly demonstrate that activation ofNrf2 target genes, and particularly HO-1, in astrocytes and neurons is strongly protective against inflammation, oxidative damage, and cell death. In the central nervous system, the HO system has been reported to be very active, and its modulation seems to play a crucial role in the pathogenesis of neurodegenerative disorders. Recent and unpublished data from our group revealed that low concentrations of epigallocatechin-3-gallate, the major green tea catechin, induces HO-1 by ARE/Nrf2 pathway in hippocampal neurons, and by this induction, it is able to protect neurons against different models of oxidative damages. Furthermore, we have demonstrated that other phenolics, such as caffeic acid phenethyl ester and ethyl ferulate, are also able to protect neurons via HO-1 induction. These studies identify a novel class of compounds that could be used for therapeutic purposes as preventive agents against cognitive decline.
Similar content being viewed by others
References
Alzheimer’s Association (2009) Alzheimer’s disease facts and figures. Alzheimers Dement 5:234–270
Rojo LE et al (2008) Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer’s disease. Arch Med Res 39:1–16
Butterfield DA et al (2001) Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid beta-peptide. Trends Mol Med 7:548–554
Halliwell B (2007) Biochemistry of oxidative stress. Biochem Soc Trans 35:1147–1150
Butterfield DA, Sultana R (2007) Redox proteomics identification of oxidatively modified brain proteins in Alzheimer’s disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 12:61–72
Katzman R, Saitoh T (1991) Advances in Alzheimer’s disease. FASEB J 5:278–286
Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of aging. Nature 408:239–247
Calabrese V et al (2004) Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. In Vivo 18:245–267
Skovronsky DM, Lee VM, Trojanowski JQ (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1:151–170
Racchi M et al (2008) Alzheimer’s disease; new diagnostic and therapeutic tools. Immun Ageing 5:7
Vatassery GT, Fahn S, Kuskowski MA (1998) The Parkinson Study Group. Alpha tocopherol in CSF of subjects taking high‑dose vitamin E in the DATATOP study. Neurology 50:1900–1902
Johnson JA et al (2008) The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann NY Acad Sci 1147:61–69
Innamorato NG et al (2008) The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181(1):680–689
Sun Z et al (2007) Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol Cell Biol 27:6334–6349
Yamamoto T et al (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28:2758–2770
Malhotra D et al (2010) Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38(17):5718–5734
Jakel RJ et al (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res 1144:192–201
Innamorato NG et al (2010) Different susceptibility to the Parkinson’s toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS ONE 5(7):e11838
Rojo AI et al (2010) Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson’s disease. Glia 58(5):588–598
Vargas MR et al (2006) Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J Neurochem 97(3):687–696
Vargas MR et al (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28(50):13574–13581
Ramsey CP et al (2007) Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 66:75–85
Kanninen K et al (2008) Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 39:302–313
Wruck CJ et al (2008) Kavalactones protect neural cells against amyloid beta peptideinduced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol 73:1785–1795
Kanninen K et al (2009) Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 106:16505–16510
Chen PC et al (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson’s disease: Critical role for the astrocyte. Proc Natl Acad Sci USA 106:2933–2938
Abraham NG, Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60(1):79–127
Takahashi M et al (2002) Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer’s disease. Neuron 28:461–473
Schipper HM (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35:821–830
Colombrita C et al (2003) Regional rat brain distribution of heme oxygenase-1 and manganese superoxide dismutase mRNA: relevance of redox homeostasis in the aging processes. Exp Biol Med 228:517–524
Chen K, Gunter K, Maines MD (2000) Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 75:304–312
Le WD, Xie WJ, Appel SH (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J Neurosci Res 56:652–658
Willis D et al (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2:87–90
Poss KD, Tonegawa S (1997) Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94:10925–10930
Yachie A et al (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 defi- ciency. J Clin Invest 103:129–135
Paine A et al (2010) Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80(12):1895–1903
Pamplona A et al (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13(6):703–710
Chora AA et al (2007) Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 117(2):438–47
Dumont M et al (2009) Triterpenoid CDDOmethylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease. J Neurochem 109(2):502–512
Son TG et al (2010) Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J Neurochem 112(5):1316–1326
Morrison CD et al (2010) High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling. J Neurochem 114(6):1581–1589
Zhao J et al (2007) Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 27:10240–10248
Dash P et al (2009) Sulforaphane improves cognitive function administered following traumatic brain injury. Neurosci Lett 460(2):103–107
Ping Z et al (2010) Sulforaphane protects brains against hypoxic-ischemic injury <!– through induction of Nrf2-dependent phase 2 enzyme. Brain Res 1343:178–185
Gomez-Pinilla F (2008) Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9:568–578
Nakatani N (2000) Phenolic antioxidants from herbs and spices. Biofactors 13:141–146
Butterfield D et al (2002) Nutritional approaches to combat oxidative stress in Alzheimer’s disease. J Nutr Biochem 13:444–461
Sun AY et al (2008) Botanical phenolics and brain health. Neuromolecular Med 10:259–274
Van Dyk K, Sano M (2007) The impact of nutrition on cognition in the elderly. Neurochem Res 32:893–904
Letenneur L et al (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165:1364–1371
Barberger-Gateau P et al (2007) Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69:921–930
Scarmeas N et al (2006) Mediterranean diet, alzheimer disease, and vascular mediation. Arch Neurol 63:1709–1717
Kang JH, Ascherio A, Grodstein F (2005) Fruit and vegetable consumption andcognitive decline in aging women. Ann Neurol 57:713–720
Commenges D et al (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16:357–363
Kim J, Lee HJ, Lee KW (2010) Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem 112(6):1415–30
Mattson MP, Son TG, Camandola S (2007) Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response 5(3):174–186
Calabrese EJ (2008) Neuroscience and hormesis: overview and general findings. Crit Rev Toxicol 38(4):249–52
Rattan SI, Fernandes RA, Demirovic D, Dymek B, Lima CF (2009) Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation. Dose Response 7(1):90–103
Martin D et al (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279:8919–8929
Surh YJ, Kundu JK, Na HK (2008) Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 74(13):1526–1539
Foresti R et al (2005) Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J Pharmacol Exp Ther 312:686–693
Ammon HPT, Wahl MA (1991) Pharmacology of Curcuma Longa. Planta Med 57:1–7
Priyadarsini KI, Guha SN, Rao MN (1998) Physicochemical properties and antioxidant activities of methoxy phenols. Free Radic Biol Med 24:933–941
Martin-Aragon S, Benedi JM, Villar AM (1997) Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment. J Pharm Pharmacol 49:49–52
Sreejayan A, Rao MN (1997) Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49:105–107
Zhao BL et al (1989) Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14:175–185
Masuda T et al (1999) Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin. J Agric Food Chem 47:71–77
Jovanovic SV et al (2001) How curcumin works preferentially with soluble antioxidants. J Am Chem Soc 123:3064–3068
Pun PB et al (2010) Ageing in nematodes: do antioxidants extend lifespan in Caenorhabditis elegans? Biogerontology 11:17–30
Ramos-Gomez M et al (2001) Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 98:3410–3415
Singh S, Aggarwal BB (1995) Activation of transcription factor NF–κB is suppressed by curcumin (diferuloylmethane). J Biol Chem 270:24995–25000
Huang MT, Newmark HL, Frenkel K (1997) Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl 27:26–34
Abe Y, Hashimoto S, Horie T (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39:41–47
Awasthi S et al (2000) Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1. Chem Biol Interact 128:19–38
Dinkova-Kostova AT, Talalay P (1999) Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis 20:911–914
Dinkova-Kostova AT et al (2001) Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 98:3404–3409
Balogun E et al (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371:887–895
Singhal SS et al (1999) The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells. Toxicol Lett 109:87–95
Motterlini R et al (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28:1303–1312
Scapagnini G et al (2002) Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 61:554–561
Scapagnini G et al (2006) Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal 8:395–403
Scapagnini G et al. (2004) Use of curcumin derivatives or CAPE in the manufacture of a medicament for the treatment of neuroprotective disorders. World Patent Number: WO 2004/075883 A1
Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as ―Curecumin||: from kitchen to clinic. Biochem Pharmacol 75:787–809
Yang C, Zhang X, Fan H, Liu Y (2009) Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 1282:133–41
Sikora E, Scapagnini G, Barbagallo M (2010) Curcumin, inflammation, ageing and age-related diseases. Immun Ageing 7(1):1
Rajakrishnan V et al (1999) Neuroprotective role of curcumin from curcuma longa on ethanol induced brain damage. Phytother Res 13:571–574
Chandra V et al (2001) Incidence of Alzheimer’s disease in a rural community in India: the Indo-US study. Neurology 57:985–989
Ng TP et al (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164:898–906
Lim GP et al (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370–8377
Frautschy SA et al (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta induced cognitive deficits and neuropathology. Neurobiol Aging 22:993–1005
Yang F et al (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J Biol Chem 280:5892–5901
Cole GM, Teter B, Frautschy SA (2007) Neuroprotective effects of curcumin. Adv Exp Med Biol 595:197–212
Begum AN et al (2008) Curcumin structure-function, bioavailability and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther 326:196–208
Baum L et al (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28:110–113
Michaluart P et al (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59:2347–2352
Natarajan K et al (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 93:9090–9095
Chen YJ, Shiao MS, Wang SY (2001) The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs 12:143–149
Huang MT et al (1996) Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells. Carcinogenesis 17:761–765
Graf E (1992) Antioxidant potential of ferulic acid. Free Radic Biol Med 13:435–448
Qureshi MJ, Blain JA (1976) Antioxidant activity in tomato extracts. Nucleus Karachi 13:29–33
Bourne LC, Rice-Evans C (1998) Biovailability of ferulic acid. Biochem Biophys Res Commun 253:222–227
Pannala R et al (1998) Inhibition of peroxynitrite dependent tyrosine nitration by hydroxycinnamates: nitration or electron donation. Free Radic Biol Med 24:594–606
Castelluccio C et al (1995) Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants. FEBS Lett 368:188–192
Bourne L, Rice-Evans C (1997) The effect of the phenolic antioxidant ferulic acid on the oxidation of low density lipoprotein depends on the pro-oxidant used. Free Radic Res 27:337–344
Kanski J et al (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure—activity studies. J Nutr Biochem 13:273–281
Clifford MN (1999) Chlorogenic acids and other cinnamates—nature, occurrence and dietary burden. J Sci Food Agric 79:362–372
Kroon PA, Williamson G (1999) Hydroxycinnamates in plants and food: current and future perspectives. J Sci Food Agric 79:355–361
Kikuzaki H et al (2002) Antioxidant properties of ferulic acid and its related compounds. J Agric Food Chem 50:2161–2168
Scapagnini G et al (2004) Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal 6:811–818
Perluigi M et al (2009) In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1–42-induced oxidative stress. J Neurosci Res 84:418–26
Sano J et al (2004) Effects of green tea intake on the development of coronary artery disease. Circ J 68:665–670
Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26:373–388
Moyers SB, Kumar NB (2004) Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev 62:204–211
Boschmann M, Thielecke F (2007) The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr 26:389–395
Potenza MA et al (2007) Epigallocatechin gallate, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces bood pressure and protects against myocardial ischemia/reperfusion injury in spontaneously hypertensive rats (SHR). Am J Physiol Endocrinol Metab 292:1378–1387
Mandel S et al (2004) Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (−)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J Neurochem 88:1555–1569
Khan N, Mukhtar H (2007) Tea polyphenols for health promotion. Life Sci 81:519–533
Ahmed S et al (2002) Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 33:1097–1105
Kim SJ et al (2007) Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J Nutr Biochem 18:587–596
Khan N, Mukhtar H (2008) Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269:269–280
Srividhya R et al (2008) Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate. Int J Dev Neurosci 26:217–223
Kweon MH et al (2006) Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem 281:33761–33772
Romeo L et al (2009) The major green tea polyphenol, (−)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr 28:492S–499S
Shah ZA, Li RC, Ahmad AS, Kensler TW, Yamamoto M, Biswal S, Doré S (2010) The flavanol (−)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J Cereb Blood Flow Metab 30(12):1951–1961
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s12035-011-8188-y
Rights and permissions
About this article
Cite this article
Scapagnini, G., Sonya, V., Nader, A.G. et al. Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders. Mol Neurobiol 44, 192–201 (2011). https://doi.org/10.1007/s12035-011-8181-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-011-8181-5